You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has received authorization to conduct a phase I/II clinical study on the quadrivalent influenza vaccine candidate Immunose FLU, a novel nose drop formulation based on the company´s technology Endocine and inactivated split antigens. Eurocine Vaccines submitted applications to the SweAlready a subscriber Login You have read all your…
The clinical stage biotechnology company has presented data on its lead compound, ONCOS-102. The data, presented in two separate podium presentations on May 7th and 8th at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT) in Mainz, Germany, demonstrated that local administrAlready a subscriber Login You have read all your free…
A surgeon previously operating at the Karolinska University Hospital in Stockholm has performed unauthorised operations and is suspected for having connections to a company that manufactures artificial tracheas. He is accused of having falisfied data and publishing wrongful information in his paperAlready a subscriber Login You have read all your free…
Full results from the positive Phase III ETHOS trial showed AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) demonstrated a statistically significant reduction in the rate of moderate or severe exacerbations compared with two dual-combinatAlready a subscriber Login You have read all your free articles, to continue reading subscribe to read…
